Akash Institute of Medical Sciences and Research Centre is recognized as Adverse Drug Reaction Monitoring Centre (AMC) by Ministry of Health and Family Welfare, Government of India under Pharmacovigilance Program of India (PvPI) on 16 June, 2017 (File no IPC/NCC-PvPI/AMCs/2017-18/17).
Surveillance and reporting of adverse drug reactions to PVPI, National Coordination Centre, Indian Pharmacopoeia commission is performed regularly. Hemovigilance programme is also active and the adverse reactions are reported on regular basis.
The committee meets quarterly to highlight the importance of ADR monitoring. The Statistics of the reported adverse drug reactions in previous months are presented in the meeting. Rare and interesting cases will be presented by department of Pharmacology in the meeting. Regular hospital visits are made by staff of pharmacology department to create awareness and remind clinicians to report the ADR regularly. Once ADRs are reported by clinicians, they are assessed by causality assessment committee and then data uploaded in Vigiflow. This meeting is also the forum where various drug related reactions are discussed in detail.
